โ† All deals

CODEXIS, INC.

Public Equity (NASDAQ)B2BBiotechnologyPublic
๐Ÿ“ Redwood City, CA, United Statesโ€ข Founded 2002
StreetZero Signal 48
Be the first to signal interest

About CODEXIS, INC.

Codexis, Inc. is a public biotechnology company founded in 2002 and headquartered in Redwood City, CA. It specializes in protein engineering and provides enzymatic solutions for efficient manufacturing of complex oligonucleotide therapeutics and other products. The company operates a B2B model and is listed on NASDAQ under ticker CDXS. It has raised over $252 million across multiple rounds since inception.

LATEST FUNDINGRule 144
$12K
Announced 2026-11-16
TOTAL RAISED$252.40M
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for CODEXIS, INC..

Free plan includes 3 full deal profiles every month.

Key highlights

  • Completed multiple public equity offerings including a 2020 underwritten offering of common stock.
  • Secured $60M term loan facility with Trinity Capital in November 2026.
  • Focuses on ECO Synthesis platform for stereo-defined siRNA manufacturing.
  • Total historical funding exceeds $252 million from institutional and strategic investors.

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account